Prostatis Group’s Vanguard Long-Term Bond ETF BLV Stock Holding History
Bought
Maintained
Sold
Other funds holding BLV
LNC
KIM
ETC
Prostatis Group's BLV Position: Q2 2026 in Review
Prostatis Group reduced its Vanguard Long-Term Bond ETF (BLV) stake by 4.8% in Q2 2026, selling an estimated $76.8K and leaving 22,319 shares worth $1.54M. The position accounts for 0.36% of the portfolio, ranked #58.
Prostatis Group first reported a position in BLV in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.09M in Q4 2023. 411 funds tracked by Wall St. Rank hold BLV as of Q2 2026.
- Prostatis Group held 22,319 shares of Vanguard Long-Term Bond ETF worth $1.54M as of Q2 2026.
- Prostatis Group sold 1,120 Vanguard Long-Term Bond ETF shares in Q2 2026, an estimated $76.8K.
- Vanguard Long-Term Bond ETF made up 0.36% of Prostatis Group's portfolio in Q2 2026, its #58 holding.
- Prostatis Group first reported a position in Vanguard Long-Term Bond ETF in Q3 2022 and has held it in 16 quarters since.
- Prostatis Group's Vanguard Long-Term Bond ETF position peaked at $2.09M in Q4 2023.
- 411 funds tracked by Wall St. Rank held Vanguard Long-Term Bond ETF as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.